EDE PHASE

EDE PHASE

EDE PHASE

EDTA (Ethylenediaminetetraacetic acid) is primarily used as an antibiotic adjuvant. By breaking down bacterial defenses, it re-sensitizes resistant pathogens—particularly Gram-negative bacteria like E. coli and K. pneumoniae—to standard antibiotics. 

Key Uses and Mechanisms Against MDR

  • Destroys Outer Membrane Permeability: EDTA chelates (binds to) divalent cations like Ca²⁺ and Mg²⁺, which are critical for stabilizing the lipopolysaccharide (LPS) outer layer of Gram-negative bacteria. Removing these ions disrupts the cell membrane, allowing antibiotics to enter the bacteria easily. 
  • Inactivates Resistance Enzymes: Many MDR bacteria produce metallo-beta-lactamases (MBLs), enzymes that destroy antibiotics and require zinc ions to function. EDTA binds to these metal ions, neutralizing the enzymes. 
  • Disrupts Bacterial Efflux Pumps: Efflux pumps actively spit antibiotics out of bacterial cells. EDTA helps disrupt the energy (ATP) balance and transporter proteins required to run these pumps.
  • Destroys Biofilms: Biofilms protect bacteria from antibiotics. EDTA weakens these protective barriers, making the bacteria vulnerable.